Literature DB >> 15083377

Aromatase: biologic relevance of tissue-specific expression.

Evan R Simpson1.   

Abstract

Aromatase p450 (p450arom) catalyzes the formation of estrogen in several human tissues under the control of alternatively used promoters. Each promoter is regulated by a distinct signaling pathway in a tissue- and hormone-specific manner. This article reviews these regulatory mechanisms in the ovary, adipose tissue, placenta, bone, brain, and various malignant cells. Moreover, the physiological and pathologic impacts of local estrogen biosynthesis in contrast to circulating estrogen or estrogen-responsive human tissues are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083377     DOI: 10.1055/s-2004-823023

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  62 in total

1.  Ontogeny of cytochrome p450 aromatase mRNA expression in the developing sheep brain.

Authors:  C E Roselli; F Stormshak
Journal:  J Neuroendocrinol       Date:  2012-03       Impact factor: 3.627

Review 2.  Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Authors:  Milica Popovic; Gideon Sartorius; Mirjam Christ-Crain
Journal:  Semin Immunopathol       Date:  2019-05-28       Impact factor: 9.623

3.  Extremes of an aromatase index predict increased 25-year risk of cardiovascular mortality in older women.

Authors:  Gail A Laughlin; Joachim H Ix; Kevin Cummins; Matthew A Allison; Lori B Daniels
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

Review 4.  Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?

Authors:  Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

Review 5.  Natural products as aromatase inhibitors.

Authors:  Marcy J Balunas; Bin Su; Robert W Brueggemeier; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2008-08       Impact factor: 2.505

Review 6.  Defects of steroidogenesis.

Authors:  A Biason-Lauber; M Boscaro; F Mantero; G Balercia
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

7.  Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI.

Authors:  Julie A Garringer; Christian Niyonkuru; Emily H McCullough; Tammy Loucks; C Edward Dixon; Yvette P Conley; Sarah Berga; Amy K Wagner
Journal:  J Neurotrauma       Date:  2013-08-15       Impact factor: 5.269

8.  Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality.

Authors:  Milap V Rakholia; Raj G Kumar; Byung-Mo Oh; Prerna R Ranganathan; Sarah L Berga; Patrick M Kochanek; Amy K Wagner
Journal:  J Neurotrauma       Date:  2018-08-24       Impact factor: 5.269

9.  Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.

Authors:  Xiying Shao; Lei Luo; Yong Guo; Xiaohong Xu; Dehou Deng; Jianguo Feng; Yuheng Ding; Hanzhou Mou; Ping Huang; Lei Shi; Yuan Huang; Weiwu Ye; Caijin Lou; Zhanhong Chen; Yabing Zheng; Xiaojia Wang
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

10.  Transforming growth factor-beta inhibits aromatase gene transcription in human trophoblast cells via the Smad2 signaling pathway.

Authors:  Hong Zhou; Guodong Fu; Hui Yu; Chun Peng
Journal:  Reprod Biol Endocrinol       Date:  2009-12-09       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.